86 related articles for article (PubMed ID: 22975371)
21. Photoactivation of Mutant Isocitrate Dehydrogenase 2 Reveals Rapid Cancer-Associated Metabolic and Epigenetic Changes.
Walker OS; Elsässer SJ; Mahesh M; Bachman M; Balasubramanian S; Chin JW
J Am Chem Soc; 2016 Jan; 138(3):718-21. PubMed ID: 26761588
[TBL] [Abstract][Full Text] [Related]
22. IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri.
Narasimhaiah D; Miquel C; Verhamme E; Desclée P; Cosnard G; Godfraind C
Neuropathology; 2012 Feb; 32(1):30-7. PubMed ID: 21481010
[TBL] [Abstract][Full Text] [Related]
23. Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome.
Watanabe T; Vital A; Nobusawa S; Kleihues P; Ohgaki H
Acta Neuropathol; 2009 Jun; 117(6):653-6. PubMed ID: 19340432
[TBL] [Abstract][Full Text] [Related]
24. A tale of two subunits: how the neomorphic R132H IDH1 mutation enhances production of αHG.
Pietrak B; Zhao H; Qi H; Quinn C; Gao E; Boyer JG; Concha N; Brown K; Duraiswami C; Wooster R; Sweitzer S; Schwartz B
Biochemistry; 2011 May; 50(21):4804-12. PubMed ID: 21524095
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndromes and malignant transformation: where the twain shall meet.
Bhagwat N; Levine RL
Sci Transl Med; 2010 Oct; 2(54):54ps50. PubMed ID: 20962328
[TBL] [Abstract][Full Text] [Related]
26. IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance.
Thota B; Shukla SK; Srividya MR; Shwetha SD; Arivazhagan A; Thennarasu K; Chickabasaviah YT; Hegde AS; Chandramouli BA; Somasundaram K; Santosh V
Am J Clin Pathol; 2012 Aug; 138(2):177-84. PubMed ID: 22904127
[TBL] [Abstract][Full Text] [Related]
27. High-throughput immunohistochemical profiling of primary brain tumors and non-neoplastic systemic organs with a specific antibody against the mutant isocitrate dehydrogenase 1 R132H protein.
Ikota H; Nobusawa S; Tanaka Y; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2011 Apr; 28(2):107-14. PubMed ID: 21213123
[TBL] [Abstract][Full Text] [Related]
28. [The modern view of the regulation of hematopoiesis].
Zakharov IuM
Fiziol Zh SSSR Im I M Sechenova; 1991 Dec; 77(12):91-101. PubMed ID: 1668746
[No Abstract] [Full Text] [Related]
29. Isocitrate dehydrogenase mutations may be a protective mechanism in glioma patients.
Zhu J; Zuo J; Xu Q; Wang X; Wang Z; Zhou D
Med Hypotheses; 2011 Apr; 76(4):602-3. PubMed ID: 21284999
[TBL] [Abstract][Full Text] [Related]
30. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
31. The Notch pathway in the developing hematopoietic system.
Bigas A; Robert-Moreno A; Espinosa L
Int J Dev Biol; 2010; 54(6-7):1175-88. PubMed ID: 20711994
[TBL] [Abstract][Full Text] [Related]
32. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
[TBL] [Abstract][Full Text] [Related]
33. Cancer: A metabolic metamorphosis.
Krall AS; Christofk HR
Nature; 2013 Apr; 496(7443):38-40. PubMed ID: 23552939
[No Abstract] [Full Text] [Related]
34. Fish provide ID(H)eas on targeting leukemia.
Trompouki E
Blood; 2015 May; 125(19):2880-2. PubMed ID: 25953976
[TBL] [Abstract][Full Text] [Related]
35. [The blood system and the organism adaptation to extreme factor].
Chereshnev VA; Iushkov BG; Sumin MN; Tiumentseva NV; Khramtsova IuS; Danilova IG
Ross Fiziol Zh Im I M Sechenova; 2004 Oct; 90(10):1193-202. PubMed ID: 15628175
[TBL] [Abstract][Full Text] [Related]
36. Genetically-defined metabolic reprogramming in cancer.
Mullen AR; DeBerardinis RJ
Trends Endocrinol Metab; 2012 Nov; 23(11):552-9. PubMed ID: 22858391
[TBL] [Abstract][Full Text] [Related]
37. Cybernetics of the red-blood-cell and bone-marrow stem-cell system.
Kirk J; Wheldon TE; Gray WM; Orr JS; Finlay HM
Int J Biomed Comput; 1970 Oct; 1(4):291-306. PubMed ID: 5520819
[No Abstract] [Full Text] [Related]
38. Clonal hematopoiesis and blood-cancer risk.
Yan B; Ban K; Chng WJ
N Engl J Med; 2015 Mar; 372(11):1071. PubMed ID: 25760362
[No Abstract] [Full Text] [Related]
39. Clonal hematopoiesis and blood-cancer risk.
Genovese G; Jaiswal S; Ebert BL; McCarroll SA
N Engl J Med; 2015 Mar; 372(11):1071-2. PubMed ID: 25760361
[No Abstract] [Full Text] [Related]
40. Human genetics: somatic mutations linked to future disease risk.
Burgess DJ
Nat Rev Genet; 2015 Feb; 16(2):69. PubMed ID: 25534323
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
